论文部分内容阅读
目的分析左氧氟沙星联合奥硝唑治疗盆腔炎的临床效果。方法选择2015年5月-2016年12月在医院接受治疗的盆腔炎患者100例,随机分为观察组和对照组各50例。对照组单独应用左氧氟沙星治疗,观察组选择左氧氟沙星联合奥硝唑治疗。比较2组患者治疗结束后腹痛消失时间、体征消失时间。治疗前后选择可视化视觉模拟评分法(VAS)对2组患者腹痛程度进行评价。观察2组治疗效果。治疗前后分别对2组患者进行一次妇科检查及阴道超声检查,检查内容需包括子宫或附件压痛、腹痛、盆腔积液、白带增多、附件包块情况。结果观察组腹痛消失时间以及体征消失时间均短于对照组,差异均有统计学意义(P<0.05)。治疗前2组腹痛程度评分结果差异无统计学意义(P>0.05),治疗后2组疼痛评分均低于治疗前,且治疗后观察组评分结果低于对照组,差异有统计学意义(P<0.05)。观察组治疗后总有效率为96.00%高于对照组的70.00%,差异有统计学意义(χ~2=11.9773,P<0.05)。治疗前2组各项症状发生率差异比较差异无统计学意义(P>0.05),治疗后2组子宫或附件压痛、腹痛、盆腔积液、白带增多、附件包块各项症状发生率明显低于治疗前,且观察组低于对照组,差异均有统计学意义(P<0.05)。结论左氧氟沙星联合奥硝唑治疗盆腔炎效果更好,值得推广。
Objective To analyze the clinical effect of levofloxacin combined with ornidazole in the treatment of pelvic inflammatory disease. Methods 100 patients with pelvic inflammatory disease who were treated in hospital from May 2015 to December 2016 were randomly divided into observation group (50 cases) and control group (50 cases). The control group was treated with levofloxacin alone, and the observation group was treated with levofloxacin or ornidazole. Comparison of two groups of patients after treatment disappeared abdominal pain, signs disappear time. Before and after treatment, visual analogue scale (VAS) was used to evaluate the degree of abdominal pain in the two groups. Observation 2 groups treatment effect. Before and after treatment, gynecological examination and vaginal ultrasonography were performed on the two groups respectively. The contents of examination should include the uterus or attachment tenderness, abdominal pain, pelvic fluid accumulation, leucorrhoea increase, and attachment mass. Results The disappearance of abdominal pain and disappearance of signs in the observation group were shorter than those in the control group, with statistical significance (P <0.05). There was no significant difference in the scores of abdominal pain between the two groups before treatment (P> 0.05). The pain scores of two groups after treatment were lower than those before treatment, and the score of observation group was lower than that of control group after treatment (P <0.05). The total effective rate in the observation group after treatment was 96.00%, which was significantly higher than that in the control group (χ ~ 2 = 11.9773, P <0.05). There was no significant difference in the incidence of various symptoms between the two groups before treatment (P> 0.05). After treatment, the incidence of tenderness, abdominal pain, pelvic fluid and leucorrhea in 2 groups of uterus or appendages were significantly increased Before treatment, and the observation group was lower than the control group, the differences were statistically significant (P <0.05). Conclusion Levofloxacin combined with ornidazole treatment of pelvic inflammatory disease better, it is worth promoting.